Skip to main content
. 2016 Nov 30;8(2):2320–2328. doi: 10.18632/oncotarget.13727

Figure 2. Best tumor size change from baseline.

Figure 2

A. Duration of response to treatment with PF-03084014 and docetaxel B. PR, partial response; PD, progressive disease; SD, stable.